Drugs / brinzolamide/brimonidine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00961649 | Oct 2009 → Feb 2010 | ocular hypertension, open-angle glaucoma | Alcon Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | brinzolamide/brimonidine | “new fixed combination of brinzolamide/brimonidine (Brinz/Brim)” NCT00961649 ↗ |
| Route | Other | “1 drop each instilled in both eyes 3 times a day for 6 weeks” NCT00961649 ↗ |